Latest Artemisia annua Stories
First shipment marks a critical step in improving access to treatment worldwide PARIS and SOUTH SAN FRANCISCO, Calif., Aug.
On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery.
Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it.
Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease supply problems and zigzagging prices for the raw material essential for making the mainstay drug for malaria.
Scientists have expressed concerns that resistance to the primary treatment for malaria is increasing, potentially putting thousands of additional people at risk of losing their lives to the disease.
The most effective anti-malaria drug can now be produced inexpensively and in large quantities.
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria.
A technique Michael Jackson reportedly used to prolong his youth is showing promise as a way to boost the effectiveness of a natural cancer remedy.
In the run up to World Malaria Day on the 25th April 2011, BioMed Central's open access journal Malaria Journal takes a long hard look at the development of natural compounds for use in the fight against malaria.
- Growing in low tufty patches.